Your browser doesn't support javascript.
loading
Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation, ß1-4 Branching, ß1-6 Branching, and α2-6 Sialylation in Cancer.
Ferdosi, Shadi; Rehder, Douglas S; Maranian, Paul; Castle, Erik P; Ho, Thai H; Pass, Harvey I; Cramer, Daniel W; Anderson, Karen S; Fu, Lei; Cole, David E C; Le, Tao; Wu, Xifeng; Borges, Chad R.
Afiliação
  • Ferdosi S; School of Molecular Sciences, Arizona State University , Tempe, Arizona 85287, United States.
  • Rehder DS; Virginia G. Piper Center for Personalized Diagnostics, The Biodesign Institute at Arizona State University , Tempe, Arizona 85287, United States.
  • Maranian P; Virginia G. Piper Center for Personalized Diagnostics, The Biodesign Institute at Arizona State University , Tempe, Arizona 85287, United States.
  • Castle EP; Virginia G. Piper Center for Personalized Diagnostics, The Biodesign Institute at Arizona State University , Tempe, Arizona 85287, United States.
  • Cramer DW; Cardiothoracic Surgery, NYU Langone Medical Center , New York, New York 10016, United States.
  • Fu L; Virginia G. Piper Center for Personalized Diagnostics, The Biodesign Institute at Arizona State University , Tempe, Arizona 85287, United States.
  • Wu X; University of Texas MD Anderson Cancer Center , Houston, Texas 77030, United States.
  • Borges CR; University of Texas MD Anderson Cancer Center , Houston, Texas 77030, United States.
J Proteome Res ; 17(1): 543-558, 2018 01 05.
Article em En | MEDLINE | ID: mdl-29129073
ABSTRACT
Glycans represent a promising but only marginally accessed source of cancer markers. We previously reported the development of a molecularly bottom-up approach to plasma and serum (P/S) glycomics based on glycan linkage analysis that captures features such as α2-6 sialylation, ß1-6 branching, and core fucosylation as single analytical signals. Based on the behavior of P/S glycans established to date, we hypothesized that the alteration of P/S glycans observed in cancer would be independent of the tissue in which the tumor originated yet exhibit stage dependence that varied little between cancers classified on the basis of tumor origin. Herein, the diagnostic utility of this bottom-up approach as applied to lung cancer patients (n = 127 stage I; n = 20 stage II; n = 81 stage III; and n = 90 stage IV) as well as prostate (n = 40 stage II), serous ovarian (n = 59 stage III), and pancreatic cancer patients (n = 15 rapid autopsy) compared to certifiably healthy individuals (n = 30), nominally healthy individuals (n = 166), and risk-matched controls (n = 300) is reported. Diagnostic performance in lung cancer was stage-dependent, with markers for terminal (total) fucosylation, α2-6 sialylation, ß1-4 branching, ß1-6 branching, and outer-arm fucosylation most able to differentiate cases from controls. These markers behaved in a similar stage-dependent manner in other types of cancer as well. Notable differences between certifiably healthy individuals and case-matched controls were observed. These markers were not significantly elevated in liver fibrosis. Using a Cox proportional hazards regression model, the marker for α2-6 sialylation was found to predict both progression and survival in lung cancer patients after adjusting for age, gender, smoking status, and stage. The potential mechanistic role of aberrant P/S glycans in cancer progression is discussed.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polissacarídeos / Glicômica / Neoplasias Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Proteome Res Assunto da revista: BIOQUIMICA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polissacarídeos / Glicômica / Neoplasias Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Proteome Res Assunto da revista: BIOQUIMICA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos